Roche closes most Alzheimer drug trials

Swiss pharmaceutical company Roche is shutting down most clinical trials of its experimental Alzheimer’s drug gantenerumab after it failed to slow the progression of febrile illness in a pair of large late-stage trials.

Share this post:

Related Posts
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore
WordPress Cookie Plugin by Real Cookie Banner